TABLE 1.

Strains collection date and Vitek-2 antibiotic susceptibility.

Isolates	Collection day	MICs (mg/L)
		AMK	CZAa	CRO	CSTa CIP	ETP	GEN	IPMa	LEV	TGCa	SXT	TGC	TZP
E. coli EC3385	10-03-2017	≤2	0.25	≥64	0.25 ≥ 4	≥8	≤1	64	≥8	0.125	≤1/19	≤0.5	≥128
PM380	10-03-2017	≤2	0.125	≥64	- ≥ 4	≥8	≥16	64	≥8	-	≥16/304	-	64
PM906	21-03-2017	≤2	0.125	≥64	- ≥ 4	≥8	≥16	64	≥8	-	≥16/304	-	64
PM431	11-03-2017	≤2	0.125	≥64	- ≥ 4	≥8	≥16	64	≥8	-	≥16/304	-	64
PM187	08-02-2017	≤2	0.125	≥64	- ≥ 4	≥8	≥16	64	≥8	-	≥16/304	-	64
E. coli ATCC 25922	NA	≤2	≤0.125	≤1	0.125 ≤0.25	≤0.5	≤1	≤1	≤0.25	0.125	≤1/19	≤0.5	≤4

^a Drug susceptibility was determined with broth microdilution method according to the Clinical Laboratory Standards Institute (CLSI) guidelines. NA, not applicable. AMK, amikacin; CZA, Ceftazidime-avibactam; CRO, ceftriaxone; CST, colistin; CIP, Ciprofloxacin; ETP, ertapenem; GEN, gentamicin; IPM, imipenem; LEV, levofloxacin; SXT, trimethoprim-sulfamethoxazole. TGC, Tigecycline, TZP, piperacillin-tazobactam.